Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2025 07:38 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Behalf

PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ: KYTX): Grabar Law Office is investigating claims on behalf of Kyverna Therapeutics, Inc. (NASDAQ: KYTX)...
March 31, 2025 08:59 ET | Source: Grabar Law Office

ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT)

PHILADELPHIA, March 31, 2025 (GLOBE NEWSWIRE) -- Holley Inc. (NYSE: HLLY) f/ka Empower Ltd. (NYSE: EMPW): Grabar Law Office is investigating whether Officers and Directors of Holley Inc (NYSE:...
March 28, 2025 08:58 ET | Source: Grabar Law Office

Notice to Long-Term Virtu Financial Inc. (NASDAQ: VIRT) Shareholders: Grabar Law Office Investigates Claims on Your Behalf as Securities Class Action Survives Motion to Dismiss

PHILADELPHIA, March 28, 2025 (GLOBE NEWSWIRE) -- A federal securities fraud class action alleging that Virtu Financial Inc. (NASDAQ: VIRT), and certain of its officers failed to disclose to...
March 24, 2025 09:13 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, March 24, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ: AKRO): Grabar Law Office is investigating whether certain officers and directors of Akero breached their...
March 21, 2025 08:32 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, March 21, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven...
March 18, 2025 16:48 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: MRCY): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, March 18, 2025 (GLOBE NEWSWIRE) -- Archer-Daniels-Midland Company (NYSE: ADM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims...
March 17, 2025 15:01 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Is Investigating Claims on Your Behalf

PHILADELPHIA, March 17, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ: FLNC): Grabar Law Office is investigating claims on behalf of Fluence Energy, Inc. (NASDAQ: FLNC) shareholders. The...
March 13, 2025 18:21 ET | Source: Grabar Law Office

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, March 13, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ: FLNC): Grabar Law Office is investigating claims on behalf of Fluence Energy, Inc. (NASDAQ: FLNC) shareholders. The...
February 04, 2025 16:23 ET | Source: Portnoy Law

Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 7, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kyverna Therapeutics, Inc....
January 29, 2025 16:56 ET | Source: Portnoy Law

Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 7, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kyverna Therapeutics, Inc....

Next Page keyboard_arrow_right